In light of these concepts, current massive transfusion protocols incorporate hemostasis-directed resuscitation, or the pre-emptive administration of blood coagulation products along with packed red ...

BURLINGTON, Vt., January 08, 2026--(BUSINESS WIRE)--Prolytix, a U.S.-based leader in bioanalytical and protein characterization services, announces it has acquired 60 validated assays previously owned ...

New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73 ...

PARIS, France—Use of a potassium ferrate hemostatic patch instead of conventional dressings following radial PCI can lead to “substantial” benefits that go beyond trimming the time to hemostasis and ...

The FDA has approved Gelfoam Plus Hemostasis Kit, a combination hemostasis product that contains Pfizer’s Gelfoam Sterile Sponge and Baxter’s Thrombin (Human) dried powder for use in controlling ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Fibrin plays a major role in stopping bleeding and healing wounds. However, if fibrin is formed in excess, e.g., in chronic wounds, thrombosis and subsequent vascular occlusions can occur. Therefore, ...

Named among the 250 best inventions of 2024, the Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes HemoSonics’ Quantra ...

HemoSonic’s diagnostic device uses ultrasound technology to quickly determine a critical factor in the operating room: hemostasis, the body’s ability to stop bleeding. It’s FDA approved for cardiac ...

A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to hemostasis for patients receiving cardiac catherization. The findings indicate a faster approach to ...